array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Gsk Consumer Health, Inc." ["slug"]=> string(32) "4abba-us-gsk-consumer-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204" ["description"]=> string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company." ["address_street"]=> string(28) "184 Liberty Corner Rd Ste 78" ["address_place"]=> string(6) "Warren" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1994-02-28" ["website_domain"]=> string(7) "gsk.com" ["website_url"]=> string(19) "https://www.gsk.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(300) ["article_count"]=> int(449) } ["articles"]=> array(5) { [0]=> array(7) { ["title_en"]=> string(66) "Med Reps: cuts for Bayer, BMS and GSK and other news in the market" ["snippet_en"]=> string(105) "Layoffs, corporate mergers and new FDA approvals are impacting the work of Med Reps. Discover what's new." ["url"]=> string(86) "https://informatori.it/flash-news/aziende/med-reps-tagli-bayer-bms-gsk-novita-mercato/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/aa700b35-9efe-48a9-afd2-20d9e09df9d8" ["source"]=> string(14) "informatori.it" ["publication_date"]=> string(10) "2024-04-02" ["categories"]=> array(3) { [0]=> string(15) "Market Movement" [1]=> string(11) "Competition" [2]=> string(7) "Layoffs" } } [1]=> array(7) { ["title_en"]=> string(82) "GSK, Sanofi Exit Nigerian Market Amid Lingering Foreign Exchange Crisis | BioSpace" ["snippet_en"]=> string(121) "The biopharma industry in Nigeria takes a hit as GSK and Sanofi shut down their commercialization efforts in the country." ["url"]=> string(104) "https://www.biospace.com/article/gsk-sanofi-exit-nigerian-market-amid-lingering-foreign-exchange-crisis/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/cf35a3fa-25e8-4551-9ec1-ae309c8c82db" ["source"]=> string(12) "biospace.com" ["publication_date"]=> string(10) "2024-02-28" ["categories"]=> array(3) { [0]=> string(8) "Downtime" [1]=> string(6) "Crisis" [2]=> string(11) "Competition" } } [2]=> array(7) { ["title_en"]=> string(50) "GSK consumer health spin-off Haleon starts trading" ["snippet_en"]=> string(299) "GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion). The new company– which has achieved the largest London listing in a decade– has annual sales of" ["url"]=> string(80) "https://pharmaphorum.com/news/gsk-consumer-health-spin-off-haleon-starts-trading" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c103aeff-d491-48f8-9773-cc329e43e37c" ["source"]=> string(16) "pharmaphorum.com" ["publication_date"]=> string(10) "2022-07-18" ["categories"]=> array(8) { [0]=> string(8) "spin-off" [1]=> string(15) "Market Movement" [2]=> string(9) "Valuation" [3]=> string(24) "Quarterly/Annual Figures" [4]=> string(11) "Competition" [5]=> string(25) "Business Model Resilience" [6]=> string(20) "Conflict of Interest" [7]=> string(12) "Going Public" } } [3]=> array(7) { ["title_en"]=> string(57) "How GSK and Sanofi won the whooping cough vaccination war" ["snippet_en"]=> string(204) "Whooping cough is facing a global resurgence which has been linked to the second generation vaccine manufactured by GSK and Sanofi. Despite this, GSK and Sanofi’s vaccine rules the Indian private market" ["url"]=> string(64) "https://the-ken.com/story/gsk-sanofi-whooping-cough-vaccination/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9e8a9490-88ce-4303-8469-c53ea512f40c" ["source"]=> string(11) "the-ken.com" ["publication_date"]=> string(10) "2019-03-12" ["categories"]=> array(2) { [0]=> string(5) "Award" [1]=> string(11) "Competition" } } [4]=> array(7) { ["title_en"]=> string(69) "Inhaler maker Vectura targets more GSK best-sellers after £100m loss" ["snippet_en"]=> string(174) "Asthma inhaler maker Vectura is targeting grabbing a bigger chunk of GSK’s leading share of the global lung drugs market, after posting worse than expected losses for 2017." ["url"]=> string(105) "https://www.telegraph.co.uk/business/2018/03/21/inhaler-maker-vectura-targets-gsk-best-sellers-100m-loss/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3bf4606f-f66f-40da-a279-dc0ab806a747" ["source"]=> string(15) "telegraph.co.uk" ["publication_date"]=> string(10) "2018-03-21" ["categories"]=> array(2) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(11) "Competition" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(28) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(26) } [3]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(21) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [5]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(18) } [6]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(17) } [7]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(16) } [8]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(15) } [9]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(14) } [10]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(14) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(13) } [12]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(12) } [13]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(11) } [14]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(10) } [15]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [16]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(8) } [19]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(6) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(6) } [23]=> array(2) { ["name"]=> string(6) "Crisis" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(6) } [27]=> array(2) { ["name"]=> string(24) "Employee Health & Safety" ["count"]=> int(6) } [28]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } } } 4abba-us-gsk-consumer-health-inc

Gsk Consumer Health, Inc.

Location

New Jersey

Founded

1994-02-28

Website

https://www.gsk.com

Articles

449 Articles

Category

Pharmaceutical Preparations

Description

GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.

Articles

Med Reps: cuts for Bayer, BMS and GSK and other news in the market

2024-04-02 (informatori.it)

Med Reps: cuts for Bayer, BMS and GSK and other news in the market

Layoffs, corporate mergers and new FDA approvals are impacting the work of Med Reps. Discover what's new.

Read more
GSK, Sanofi Exit Nigerian Market Amid Lingering Foreign Exchange Crisis | BioSpace

2024-02-28 (biospace.com)

GSK, Sanofi Exit Nigerian Market Amid Lingering Foreign Exchange Crisis | BioSpace

The biopharma industry in Nigeria takes a hit as GSK and Sanofi shut down their commercialization efforts in the country.

Read more
GSK consumer health spin-off Haleon starts trading

2022-07-18 (pharmaphorum.com)

GSK consumer health spin-off Haleon starts trading

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion). The new company– which has achieved the largest London listing in a decade– has annual sales of

Read more
How GSK and Sanofi won the whooping cough vaccination war

2019-03-12 (the-ken.com)

How GSK and Sanofi won the whooping cough vaccination war

Whooping cough is facing a global resurgence which has been linked to the second generation vaccine manufactured by GSK and Sanofi. Despite this, GSK and Sanofi’s vaccine rules the Indian private market

Read more
Inhaler maker Vectura targets more GSK best-sellers after £100m loss

2018-03-21 (telegraph.co.uk)

Inhaler maker Vectura targets more GSK best-sellers after £100m loss

Asthma inhaler maker Vectura is targeting grabbing a bigger chunk of GSK’s leading share of the global lung drugs market, after posting worse than expected losses for 2017.

Read more

Newsletter subscription